Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Biotin is a water-soluble vitamin (B7/H) with a fused ring structure (ureido and tetrahydrothiophene) and a valeric acid side chain, functioning as a coenzyme in carboxylase enzymes that mediate key steps in metabolism (fatty acid synthesis, breakdown of amino acids, gluconeogenesis). Found in most tissues and synthesized by intestinal bacteria, biotin deficiency often leads to metabolic and neurological disorders. Biotin’s tight binding to proteins like avidin/streptavidin facilitates its extensive use in biotechnology. It is not itself a direct target for pharmaceuticals, but it is essential for normal cellular physiology and is commonly included in vitamin supplements.
As a coenzyme, biotin binds carboxylase enzymes, facilitating transfer of CO₂ in metabolic reactions Non-drug mechanism of action: carrier for carboxylation reactions in metabolism In laboratory applications: biotin’s high-affinity binding to avidin/streptavidin is used in assays and molecular biology
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Biotin.